OR WAIT null SECS
March 08, 2022
Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.
What if we are underestimating China’s response to US/EU inshoring?
March 07, 2022
Researchers at McGill University have made advancements with a novel method for growing synthetic bone tissue.
March 04, 2022
FDA’s CDER continues to make rare diseases a priority with drug approvals and programming to speed therapeutic development.
EMA’s PRIME scheme has enabled life-changing medicines to become available to patients at a faster rate.
MHRA has awarded Promising Innovation Medicine (PIM) designation to rezafungin for the treatment of invasive candidiasis.
Evonik has increased its global supply of plant-derived cholesterol used for mRNA vaccines and gene therapies.
March 03, 2022
TFF Pharmaceuticals and Catalent will collaborate to develop TFF's platform for manufacturing dry powder particles.
In a goal to boost local pharmaceutical production, the World Health Organization has established a global manufacturing training hub in the Republic of Korea through which Bangladesh, Indonesia, Pakistan, Serbia, and Vietnam will receive mRNA technology.
March 02, 2022
Pfizer has received Breakthrough Therapy Designation from FDA for its RSV vaccine candidate for prevention of RSV illness in infants by active immunization of pregnant women.